Efficacy and tolerability of clozapine in Japanese patients with treatment-resistant schizophrenia: Results from a 12-week, flexible dose study using raters masked to antipsychotic choice
- 3 December 2012
- journal article
- research article
- Published by Elsevier BV in Asian Journal of Psychiatry
- Vol. 6 (3), 200-207
- https://doi.org/10.1016/j.ajp.2012.10.007
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
- Ministry of Education
- Japan Health Sciences Foundation
- Japan Research Foundation for Clinical Pharmacology
- Ministry of Health, Labour and Welfare
This publication has 21 references indexed in Scilit:
- When can patients with potentially life-threatening adverse effects be rechallenged with clozapine? A systematic review of the published literatureSchizophrenia Research, 2012
- A user’ guide to clozapineActa Psychiatrica Scandinavica, 2011
- Antipsychotic drugs and obesityTrends in Molecular Medicine, 2011
- Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: A systematic review and meta-analysisSchizophrenia Research, 2010
- Clozapine versus other atypical antipsychotics for schizophreniaEmergencias, 2010
- Antipsychotics Associated with the Development of Type 2 Diabetes in Antipsychotic-Naïve Schizophrenia PatientsNeuropsychopharmacology, 2010
- A Meta-Analysis of Head-to-Head Comparisons of Second-Generation Antipsychotics in the Treatment of SchizophreniaAmerican Journal of Psychiatry, 2009
- Clozapine versus typical neuroleptic medication for schizophreniaEmergencias, 2009
- Active monitoring of 12760 clozapine recipients in the UK and IrelandThe British Journal of Psychiatry, 1999
- Treatment-Resistant Schizophrenia - The Role of ClozapineCurrent Medical Research and Opinion, 1997